To access this element change to forms mode OFF

Current Grant Opportunity View - GO5481

2022 Priority-driven Collaborative Cancer Research Scheme for funding commencing 2023

GO ID:
GO5481
Agency:
Cancer Australia
Close Date & Time:
31-Aug-2022 5:00 pm (ACT Local Time)
Show close time for other time zones
Internal Reference ID:
2022 PdCCRS
Primary Category:
231004 - Cancer
Publish Date:
9-Mar-2022
Location:
ACT, NSW, VIC, SA, WA, QLD, NT, TAS
Selection Process:
Targeted or Restricted Competitive

Description:

The Priority-driven Collaborative Cancer Research Scheme is an innovative annual national research project grants funding scheme which brings together government and other funders to collaboratively fund cancer research in Australia.

Eligibility:

PdCCRS applications are invited from appropriately qualified researchers affiliated with an NHMRC approved Administering Institution. Applicants must be Australia or New Zealand citizens, a permanent resident or hold a valid work visa, and be present in Australia for 80% of the project period.

Applicants must submit an Ideas grant application or a Clinical Trials and Cohort Studies grant application to NHMRC through Sapphire indicating the application is to be considered for funding by Cancer Australia. In addition to submission of an NHMRC grant application, a completed PdCCRS Questions form must be submitted directly to Cancer Australia.

The Chief Investigator A (CIA) must be the same person as nominated as CIA on the NHMRC application. The CIA can only submit a maximum of two applications to the 2022 round of the PdCCRS. Each NHMRC application ID can only be used to apply for one Cancer Australia grant and should be for the most relevant funding category, i.e., A, B, or C.

Applications must be submitted to NHMRC and to Cancer Australia by the closing time and date as published in the relevant grant guidelines. The proposed research must directly align with at least one research priority area specified by Cancer Australia or its Funding Partners.

Standard PdCCRS applications can be submitted through the NHMRC Ideas Grants or Clinical Trials and Cohort Studies grants schemes and must satisfy all the requirements set out in the NHMRC Grant Guidelines as published on GrantConnect in addition to satisfying the requirements as set out in the 2022 PdCCRS Grant Guidelines.

Early Career Researcher (ECR) PdCCRS applications can be submitted through the NHMRC Ideas Grants scheme only and the NHMRC application must not exceed 3 years duration. ECR applications must satisfy all the requirements set out in the NHMRC Ideas Grant Guidelines as published on GrantConnect in addition to satisfying the requirements as set out in the 2022 PdCCRS Grant Guidelines.

Grant Activity Timeframe:

All grants must commence no later than 30 June 2023.

Category A – up to 3 years

Category B – 1 year

Category C – 2 years

Total Amount Available (AUD):

$3,900,000.00

Estimated Grant Value (AUD):

From $10,000.00 to $600,000.00

Instructions for Application Submission:

Applicants are required to complete and submit a grant application to the National Health and Medical Research Council (NHMRC) Ideas Grants or Clinical Trials and Cohort Studies Grants schemes via Sapphire, indicating that the application is to be considered for funding by Cancer Australia.

Applicants are also required to complete the relevant PdCCRS Questions application form for submission by the Administering Institution RAO directly to Cancer Australia at grants@canceraustralia.gov.au.